Rocket Pharmaceuticals, Inc.
RCKT· Nasdaq
Released Nov 6, 2020, after the close
10-Q filed Nov 6, 2020, 37 days after period end · 0001140361-20-024856
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$29.08M | -$19.28M | -$16.09M | -$6.72M |
| EPS Diluted | -$0.53 |
Rocket Pharmaceuticals, Inc. · CIK 1281895 · Engraved from SEC EDGAR
| -$0.38 |
| -$0.40 |
| -$0.99 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.